Received: 28 October 2022
Accepted: 6 April 2023
First Online: 25 April 2023
: This trial was performed according to the principles outlined by the World Medical Association’s Declaration of Helsinki on experimentation involving human subjects, as revised in 2000, and was approved by the Tabriz University of Medical Sciences ethics committee with the approval number IR.TBZMED.REC.1400.387 on 02/08/2021. Also, this study was registered to the Iranian Registry of Clinical Trials (IRCT) with the approval number IRCT20220104053626N2 on 13/02/2022. Patients signed and accepted informed consent papers; their participation in this trial and the data they provided are completely confidential.
: Not applicable.
: The authors declare to have no financial and non-financial competing interests related to this work.